Zealand Pharma A/S
ZLDPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,078,828 | -$703,739 | -$1,202,135 | -$1,018,149 |
| Dep. & Amort. | $25,847 | $25,086 | $117,961 | $40,249 |
| Deferred Tax | $0 | $0 | $0 | -$1,190 |
| Stock-Based Comp. | $87,032 | $61,426 | $52,286 | $53,504 |
| Change in WC | $122,379 | $52,103 | $10,263 | -$166,325 |
| Other Non-Cash | -$87,246 | $139,456 | $79,126 | -$120,060 |
| Operating Cash Flow | -$930,816 | -$425,668 | -$942,209 | -$1,211,971 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10,053 | -$11,241 | -$11,710 | -$22,133 |
| Net Acquisitions | $0 | $0 | $106,386 | $0 |
| Inv. Purchases | -$11,457,664 | -$2,159,831 | -$700,477 | $0 |
| Inv. Sales/Matur. | $4,137,897 | $1,089,547 | $887,060 | $0 |
| Other Inv. Act. | -$3,095 | -$12,508 | $292,969 | $4,012 |
| Investing Cash Flow | -$7,332,915 | -$1,094,033 | $281,259 | -$18,121 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $369,867 | -$525,764 | -$436,088 | $647,906 |
| Stock Issued | $8,523,479 | $1,563,950 | $1,084,661 | $775,045 |
| Stock Repurch. | -$351,834 | -$41,600 | $0 | -$28,590 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$253,021 | -$89,572 | -$61,073 | -$836,655 |
| Financing Cash Flow | $8,288,491 | $907,014 | $587,398 | $1,332,751 |
| Forex Effect | $6,232 | -$7,236 | $13,683 | $66,223 |
| Net Chg. in Cash | $30,992 | -$619,923 | -$59,869 | $168,882 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $449,311 | $1,069,234 | $1,129,103 | $960,221 |
| End Cash | $480,303 | $449,311 | $1,069,234 | $1,129,103 |
| Free Cash Flow | -$943,964 | -$449,417 | -$953,919 | -$1,234,104 |